Stability in Vitiligo: Is there a Perfect Way to Predict it? (Q38136173)

29 August 2017

Stability in Vitiligo: Is there a Perfect Way to Predict it? (English)

1 reference

29 August 2017

1 reference

Davinder Parsad

2

0 references

author name string

Kanika Sahni

series ordinal

1

1 reference

PMC publication ID

3764766

29 August 2017

language of work or name

English

0 references

publication date

1 April 2013

1 reference

Journal of Cutaneous and Aesthetic Surgery

29 August 2017

1 reference

29 August 2017

6

1 reference

29 August 2017

2

1 reference

29 August 2017

75-82

1 reference

Reduced skin homing by functional Treg in vitiligo

29 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3764766

Autoantigens in vitiligo identified by the serological selection of a phage-displayed melanocyte cDNA expression library.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3764766

A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3764766

A comparative study of oxidant-antioxidant status in stable and active vitiligo patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3764766

Long-term follow-up study of segmental and focal vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3764766

A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3764766

Catecholamines and vitiligo

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3764766

Repigmentation in vitiligo vulgaris by autologous minigrafting: results in nineteen patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3764766

Standard guidelines of care for vitiligo surgery

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3764766

Relation Between the Incidence and Level of Pigment Cell Antibodies and Disease Activity in Vitiligo

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3764766

The concept of stability of vitiligo: a reappraisal

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3764766

Catecholamines increase in the urine of non-segmental vitiligo especially during its active phase

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3764766

Clinical and histopathologic characteristics of trichrome vitiligo

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3764766

Clinical characteristics of progressive vitiligo

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3764766

Granulocyte/macrophage colony-stimulating factor is an intrinsic keratinocyte-derived growth factor for human melanocytes in UVA-induced melanosis

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3764766

Vitiligo autoantibodies are effective against melanoma

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3764766

Epidermal Changes in Active Vitiligo

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3764766

Identification of pigment cell antigens defined by vitiligo antibodies

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3764766

Clinical features and histological findings are potential indicators of activity in lesions of common vitiligo

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3764766

Increased level of serum Homocysteine in vitiligo

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3764766

Antioxidant enzymes and lipid peroxidation at the tissue level in patients with stable and active vitiligo.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3764766

T cell subpopulations and IL-2R in vitiligo

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3764766

Inflammatory changes in vitiligo: stage I and II depigmentation

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3764766

Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3764766

An immunohistological study of cutaneous lymphocytes in vitiligo

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3764766

Autoantibodies against tyrosine hydroxylase in patients with non-segmental (generalised) vitiligo

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3764766

In Vivo Destruction of Melanocytes by the IgG Fraction of Serum from Patients with Vitiligo

1 October 2018

1 reference

12 December 2020

Preliminary evaluation of vitiligo using in vivo reflectance confocal microscopy

1 reference

12 December 2020

Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay

1 reference

12 December 2020

Study of clinical, biochemical and immunological factors determining stability of disease in patients with generalized vitiligo undergoing melanocyte transplantation

1 reference

12 December 2020

Correlation between vitiligo antibodies and extent of depigmentation in vitiligo

1 reference

12 December 2020

The role of tyrosinase in autoimmune vitiligo

1 reference

12 December 2020

Tyrosinase as an autoantigen in patients with vitiligo

1 reference

12 December 2020

Vitiligo antibodies are not directed to tyrosinase

1 reference

12 December 2020

Levels of neuropeptide-Y in the plasma and skin tissue fluids of patients with vitiligo

1 reference

12 December 2020

Immunohistochemical studies from vitiligo--comparison between active and inactive lesions

1 reference

12 December 2020

Increased interleukin-6 and granulocyte-macrophage colony stimulating factor levels in the sera of patients with non-segmental vitiligo

1 reference

12 December 2020

The minigrafting test for vitiligo: detection of stable lesions for melanocyte transplantation

1 reference

12 December 2020

How unstable is the concept of stability in surgical repigmentation of vitiligo?

1 reference

12 December 2020

Surgical treatment of vitiligo: why, when and how

1 reference

12 December 2020

Detection of Antibodies to Melanocytes in Vitiligo by Specific Immunoprecipitation

1 reference

12 December 2020

Role of apoptosis and melanocytorrhagy: a comparative study of melanocyte adhesion in stable and unstable vitiligo

1 reference

12 December 2020

Catechol-O-methyltransferase in vitiligo

1 reference

12 December 2020

The minigrafting test for vitiligo: detection of stable lesions for melanocyte transplantation

1 reference

12 December 2020

Clinico-cellular stability of vitiligo in surgical repigmentation: an unexplored frontier

1 reference

12 December 2020

Association of the Köbner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris

1 reference

12 December 2020

Coexistence and relationship of antikeratinocyte and antimelanocyte antibodies in patients with non-segmental-type vitiligo

1 reference

12 December 2020

Autologous miniature skin punch grafting in vitiligo

1 reference

12 December 2020

Detection of antibodies to melanocytes in vitiligo by western immunoblotting

1 reference

12 December 2020

Treatment of refractory and stable vitiligo by transplantation of in vitro cultured epidermal autografts bearing melanocytes

1 reference

12 December 2020

Abnormal expression of MHC class II and ICAM-1 by melanocytes in vitiligo

1 reference

12 December 2020

The change of melanocyte cytotoxicity after systemic steroid treatment in vitiligo patients

1 reference

12 December 2020

Cytolytic antibodies to melanocytes in vitiligo

1 reference

12 December 2020

Characterization of vitiligo antigens

1 reference

12 December 2020

Identifiers

DOI

10.4103/0974-2077.112667

1 reference

29 August 2017

1 reference

PMC publication ID

3764766

29 August 2017

PubMed publication ID

24023428

1 reference

PMC publication ID

3764766